Carregant...
Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells
INTRODUCTION: Tamoxifen is a drug of choice for endocrine-responsive breast tumor patients. However, tamoxifen resistance has become a major concern for the treatment of breast cancer. Combinational therapies of tamoxifen and different drugs are being frequently studied. In the current study, we tes...
Guardat en:
| Publicat a: | Anticancer Drugs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378591/ https://ncbi.nlm.nih.gov/pubmed/19966541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e328333d557 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|